Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases.

Erster O, Thomas JM, Hamzah J, Jabaiah AM, Getz JA, Schoep TD, Hall SS, Ruoslahti E, Daugherty PS.

J Control Release. 2012 Aug 10;161(3):804-12. doi: 10.1016/j.jconrel.2012.05.035. Epub 2012 May 23.

2.

IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.

Zhang W, Tang T, Nie D, Wen S, Jia C, Zhu Z, Xia N, Nie S, Zhou S, Jiao J, Dong W, Lv B, Xu T, Sun B, Lu Y, Li Y, Cheng L, Liao Y, Cheng X.

Cardiovasc Res. 2015 Jun 1;106(3):453-64. doi: 10.1093/cvr/cvv110. Epub 2015 Mar 17.

PMID:
25784693
3.

Specific targeting of atherosclerotic plaques in ApoE(-/-) mice using a new Camelid sdAb binding the vulnerable plaque marker LOX-1.

De Vos J, Mathijs I, Xavier C, Massa S, Wernery U, Bouwens L, Lahoutte T, Muyldermans S, Devoogdt N.

Mol Imaging Biol. 2014 Oct;16(5):690-8. doi: 10.1007/s11307-014-0731-6.

PMID:
24687730
4.

18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1213-22. doi: 10.1016/j.jcmg.2009.04.016.

5.

In vivo molecular imaging of atherosclerotic lesions in ApoE-/- mice using VCAM-1-specific, 99mTc-labeled peptidic sequences.

Dimastromatteo J, Broisat A, Perret P, Ahmadi M, Boturyn D, Dumy P, Fagret D, Riou LM, Ghezzi C.

J Nucl Med. 2013 Aug;54(8):1442-9. doi: 10.2967/jnumed.112.115675. Epub 2013 May 29.

6.

Effect of atorvastatin on the expression of gamma-glutamyl transferase in aortic atherosclerotic plaques of apolipoprotein E-knockout mice.

Li G, Wu XW, Lu WH, Ai R, Chen F, Tang ZZ.

BMC Cardiovasc Disord. 2014 Oct 18;14:145. doi: 10.1186/1471-2261-14-145.

7.

Molecular targeting of atherosclerotic plaques by a stabilin-2-specific peptide ligand.

Lee GY, Kim JH, Oh GT, Lee BH, Kwon IC, Kim IS.

J Control Release. 2011 Oct 30;155(2):211-7. doi: 10.1016/j.jconrel.2011.07.010. Epub 2011 Jul 14.

PMID:
21781994
8.

Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice.

Park JG, Ryu SY, Jung IH, Lee YH, Kang KJ, Lee MR, Lee MN, Sonn SK, Lee JH, Lee H, Oh GT, Moon K, Shim H.

Atherosclerosis. 2013 Feb;226(2):356-63. doi: 10.1016/j.atherosclerosis.2012.11.029. Epub 2012 Dec 5.

PMID:
23245509
9.

Pivotal role of serum- and glucocorticoid-inducible kinase 1 in vascular inflammation and atherogenesis.

Borst O, Schaub M, Walker B, Schmid E, Münzer P, Voelkl J, Alesutan I, Rodríguez JM, Vogel S, Schoenberger T, Metzger K, Rath D, Umbach A, Kuhl D, Müller II, Seizer P, Geisler T, Gawaz M, Lang F.

Arterioscler Thromb Vasc Biol. 2015 Mar;35(3):547-57. doi: 10.1161/ATVBAHA.114.304454. Epub 2015 Jan 22.

10.

TLR3 deficiency protects against collagen degradation and medial destruction in murine atherosclerotic plaques.

Ishibashi M, Sayers S, D'Armiento JM, Tall AR, Welch CL.

Atherosclerosis. 2013 Jul;229(1):52-61. doi: 10.1016/j.atherosclerosis.2013.03.035. Epub 2013 Apr 9.

11.

Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.

Fraga-Silva RA, Montecucco F, Costa-Fraga FP, Nencioni A, Caffa I, Bragina ME, Mach F, Raizada MK, Santos RA, da Silva RF, Stergiopulos N.

Vascul Pharmacol. 2015 Nov;74:103-13. doi: 10.1016/j.vph.2015.08.014. Epub 2015 Aug 22.

PMID:
26304699
12.

Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives.

Burtea C, Ballet S, Laurent S, Rousseaux O, Dencausse A, Gonzalez W, Port M, Corot C, Vander Elst L, Muller RN.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):e36-48. doi: 10.1161/ATVBAHA.112.245415. Epub 2012 Apr 19. Erratum in: Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):e103.

13.

Ginkgolide B reduces atherogenesis and vascular inflammation in ApoE(-/-) mice.

Liu X, Zhao G, Yan Y, Bao L, Chen B, Qi R.

PLoS One. 2012;7(5):e36237. doi: 10.1371/journal.pone.0036237. Epub 2012 May 11.

14.

A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content.

McAteer MA, Mankia K, Ruparelia N, Jefferson A, Nugent HB, Stork LA, Channon KM, Schneider JE, Choudhury RP.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1427-35. doi: 10.1161/ATVBAHA.111.241844. Epub 2012 Apr 12.

15.

Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice.

Wang L, Wang W, Shah PK, Song L, Yang M, Sharifi BG.

Cardiovasc Pathol. 2012 Sep-Oct;21(5):398-413. doi: 10.1016/j.carpath.2011.12.005. Epub 2012 Feb 1.

16.

Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies.

Fiechter M, Frey K, Fugmann T, Kaufmann PA, Neri D.

Atherosclerosis. 2011 Feb;214(2):325-30. doi: 10.1016/j.atherosclerosis.2010.11.027. Epub 2010 Nov 27.

PMID:
21167484
17.

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.

Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M.

Cardiovasc Res. 2014 Feb 1;101(2):236-46. doi: 10.1093/cvr/cvt245. Epub 2013 Nov 4.

PMID:
24193738
18.

Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.

Li MW, Mian MO, Barhoumi T, Rehman A, Mann K, Paradis P, Schiffrin EL.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2306-15. doi: 10.1161/ATVBAHA.113.302028. Epub 2013 Jul 25.

19.

Atheroprotective role of C5ar2 deficiency in apolipoprotein E-deficient mice.

Selle J, Asare Y, Köhncke J, Alampour-Rajabi S, Shagdarsuren G, Klos A, Weber C, Jankowski J, Shagdarsuren E.

Thromb Haemost. 2015 Oct;114(4):848-58. doi: 10.1160/TH14-12-1075. Epub 2015 Jun 18.

PMID:
26084965
20.

Molecular imaging of atherosclerotic plaques using a human antibody against the extra-domain B of fibronectin.

Matter CM, Schuler PK, Alessi P, Meier P, Ricci R, Zhang D, Halin C, Castellani P, Zardi L, Hofer CK, Montani M, Neri D, Lüscher TF.

Circ Res. 2004 Dec 10;95(12):1225-33. Epub 2004 Nov 11.

Supplemental Content

Support Center